Kim Jung Sue, Bellew Christine A, Silverstein Douglas M, Aviles Diego H, Boineau Frank G, Vehaskari V Matti
Department of Pediatrics, Louisiana State University Health Sciences Center and Children's Hospital, New Orleans, Louisiana 70118, USA.
Kidney Int. 2005 Sep;68(3):1275-81. doi: 10.1111/j.1523-1755.2005.00524.x.
Conventional wisdom states that greater than 80% of children with nephrotic syndrome (NS) respond to steroid treatment, remain steroid-sensitive during subsequent relapses, and consequently have a favorable long-term prognosis. In contrast, steroid resistance is believed to be associated with a high risk of developing chronic renal failure. Recent reports suggest that the histologic pattern of NS in children may be changing, but whether the change is accompanied by a parallel change in steroid sensitivity is unknown.
Initial and subsequent steroid responsiveness was evaluated in all children aged 1 to 18 years who presented with newly diagnosed NS to the 2 pediatric nephrology referral centers in southeastern Louisiana between 1994 and 2003. NS was defined as presence of edema, heavy proteinuria, and serum albumin concentration below 2.5 g/dL. Steroid sensitivity (SS) was defined as total resolution of proteinuria and edema, and partial response to steroids (PR) was defined as loss of edema with continuing proteinuria.
There were 210 new cases of NS. Forty-one patients (20%) had immune complex glomerulonephritis. Six patients were excluded because of incomplete data availability. Of the remaining 163 patients, 115 (71%) were SS and 23 (14%) achieved PR during the initial 4 weeks of treatment; 25 (15%) were steroid-resistant (SR). Follow-up data were available for 91 of the 115 initially SS patients; 19 subsequently became steroid-resistant. Thus, at least 45% of the patients with new-onset NS did not have typical childhood steroid-responsive NS. Initial steroid resistance was more likely in African American children and in children with older age at onset (11.5 vs. 4.6 years). Development of steroid resistance after initial SS was associated with shorter interval to the first relapse (2.2 vs. 5.4 months) and having the first relapse during the initial steroid treatment.
Compared to previous reports, our results show a higher incidence of initial and subsequent steroid resistance, characteristics not consistent with typical minimal change NS with a benign prognosis. The results suggest that in the current era, NS in children may not be as benign as indicated by earlier studies.
传统观点认为,超过80%的肾病综合征(NS)患儿对类固醇治疗有反应,在随后的复发中仍对类固醇敏感,因此长期预后良好。相比之下,类固醇抵抗被认为与发生慢性肾衰竭的高风险相关。最近的报告表明,儿童NS的组织学模式可能正在发生变化,但这种变化是否伴随着类固醇敏感性的平行变化尚不清楚。
对1994年至2003年间在路易斯安那州东南部的2个儿科肾病转诊中心新诊断为NS的所有1至18岁儿童进行初始和后续类固醇反应性评估。NS定义为存在水肿、大量蛋白尿以及血清白蛋白浓度低于2.5g/dL。类固醇敏感性(SS)定义为蛋白尿和水肿完全消退,对类固醇的部分反应(PR)定义为水肿消退但蛋白尿持续存在。
共有210例新诊断的NS病例。41例患者(20%)患有免疫复合物性肾小球肾炎。6例患者因数据不完整被排除。在其余163例患者中,115例(71%)为SS,23例(14%)在治疗的最初4周内达到PR;25例(15%)为类固醇抵抗(SR)。115例最初为SS的患者中有91例有随访数据;其中19例随后变为类固醇抵抗。因此,至少45%的新发NS患者没有典型的儿童类固醇反应性NS。初始类固醇抵抗在非裔美国儿童和发病年龄较大(11.5岁对4.6岁)的儿童中更常见。初始SS后发生类固醇抵抗与首次复发间隔时间较短(2.2个月对5.4个月)以及在初始类固醇治疗期间首次复发有关。
与先前的报告相比,我们的结果显示初始和后续类固醇抵抗的发生率更高,这些特征与预后良好的典型微小病变NS不一致。结果表明,在当前时代,儿童NS可能不像早期研究所表明的那样良性。